Ken Kilgore earned his undergraduate and M.S. (Cell Biology) degrees from Western Michigan University, Kalamazoo, Michigan in 1987 and 1989, respectively. In 1993, he obtained his Ph.D. in Pharmacology at the University of Michigan followed by postdoctoral training in the Department of Pathology (University of Michigan).Ken has held a series of positions in the pharmaceutical industry with stops at Pfizer and GlaxoSmithKline, where he was Head of Translational Pharmacology for the ImmunoInflammation Center of Excellence. In 2009, he joined Janssen Pharmaceuticals, where he established the ImmunoPharmacology Group (Immunology TA) which focused on in vivo modeling and translational sciences. He completed his Executive MBA at St. Joseph’s University (Philadelphia, PA) in 2014 and is an author on over 60 scientific publications.